Nanomolar Inhibitors of Staphylococcus aureus Methionyl tRNA Synthetase with Potent Antibacterial Activity against Gram-Positive Pathogens
- 9 April 2002
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 45 (10), 1959-1962
- https://doi.org/10.1021/jm025502x
Abstract
Potent nanomolar inhibitors of Staphylococcus aureus methionyl tRNA synthetase have been derived from a file compound high throughput screening hit. Optimized compounds show excellent antibacterial activity against staphylococcal and enterococcal pathogens, including strains resistant to clinical antibiotics. Compound 11 demonstrated in vivo efficacy in an S. aureus rat abscess infection model.Keywords
This publication has 7 references indexed in Scilit:
- Cryptococcosis in Patients with CancerClinical Infectious Diseases, 2001
- Aminoacyl-tRNA SynthesisAnnual Review of Biochemistry, 2000
- Synthesis and Activity of Analogues of SB-219383. Novel Potent Inhibitors of Bacterial Tyrosyl tRNA Synthetase.The Journal of Antibiotics, 2000
- Molecular recognition of tyrosinyl adenylate analogues by prokaryotic tyrosyl tRNA synthetasesBioorganic & Medicinal Chemistry, 1999
- Aminoacyl-tRNA synthetases: A new image for a classical familyBiochimie, 1999
- Occurrence of the regulatory nucleotides ppGpp and pppGpp following induction of the stringent response in staphylococciJournal of Bacteriology, 1995
- Quantitation of guanosine 5′,3′-bisdiphosphate in extracts from bacterial cells by ion-pair reverse-phase high-performance liquid chromatographyAnalytical Biochemistry, 1982